![]() The Pricing and Market Access arc is centered around the team’s broad therapeutic expertise combined with a deep understanding of the underlying business objectives, incentives, and historical behaviors of key access decision makers and influencers, giving clients the advantage to gain and maintain commercial success. The designated areas that fall under the Strategic Arcs include: The company’s combined years of experience developing unique programs for biopharma businesses enables them to implement impactful advisory and tactical services to support the challenging decisions required to succeed in these functional areas. Triangle's expertise encompasses key therapeutic areas (oncology, CNS, cell, and gene therapy) and relevant industry disciplines (pricing and market access, new product planning, and commercial strategy).Triangle Insights Group, a premier life sciences consulting firm, announced today the launch of its Strategic Arcs, dedicated to helping pharma and biotech companies enrich their therapeutic offerings worldwide.ĭesigned to formalize the company’s current areas of expertise, Triangle’s Arcs comprise multi-disciplinary teams of scientific and consultative experts who are adept at strategy and execution across the commercial development and product lifecycle. The firm's approach combines deep industry knowledge with strong analytical rigor to drive strategic decision-making across client domains. Triangle Insights Group is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. For more information about TrialCard, please visit About Triangle Insights Group ![]() The company is headquartered in Morrisville, North Carolina. Founded in 2000, TrialCard provides commercialization support for more than 400 life science customers and has connected over 36 million patients with more than $22 billion in branded drug savings to date. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial supply management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. TrialCard Incorporated is a full-service life sciences commercialization company that provides comprehensive solutions that span the entire biopharmaceutical value chain. In February 2022, Triangle Insights Group was ranked #6 among the Best Boutique Consulting Firms in the 2022 Vault Rankings.Ĭlearsight Advisors served as the exclusive financial advisor to Triangle Insights in connection with this transaction. ![]() This ranking is based on revenue growth over the past three years and represents the most successful companies within the American economy's most dynamic segment-its independent small businesses. 5000 list as one of the fastest-growing companies in the nation. This growth-accelerating transaction will provide incredible opportunities for our Triangle team and will enable us to continue our trend of attracting top-caliber talent."įor the past four years, Triangle Insights Group has been ranked on Inc. "Our strategic capabilities, combined with TrialCard's industry-leading suite of patient support and provider engagement services, will enable us to offer unparallelled value to our clients. "We are thrilled to be part of TrialCard's innovative full-service commercialization platform," added Gautam Aggarwal, Founding Partner and Pricing Market Access Lead at Triangle Insights Group. Our blended team of experts will be well-positioned to provide both the strategic insights and executional excellence to successfully launch and commercialize new products." "Commercialization and operational considerations are becoming increasingly important during the early pre-approval stages of a product's lifecycle. "The addition of Triangle Insights Group to the TrialCard platform is a huge win for the life sciences industry and patients in general," said Scott Dulitz, President and Chief Strategy Officer at TrialCard. ![]() TrialCard is pleased to announce that all TIG partners and employees will be retained by TrialCard post-acquisition. The company, founded in 2013, supports clients in the biopharmaceutical, diagnostics, and medical device industries, with experience in every therapeutic area and more than 150 indications. Recommendations from Triangle Insights Group are original, relevant to the evolving industry landscape, and supported by rigorous analytics. Headquartered in Durham, North Carolina, with offices in New York City and San Francisco, Triangle Insights Group's 50+ consultants combine deep knowledge of the life sciences industry across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |